Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apoptosis-based therapies.

John C Reed1

  • 1Burnham Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA. jreed@burnham.org

Nature Reviews. Drug Discovery
|July 18, 2002
PubMed
Summary
This summary is machine-generated.

Problems with apoptosis, a programmed cell-suicide process, underlie many diseases. Understanding apoptosis regulation is key to developing new therapies for conditions involving cell accumulation or loss.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

K63 ubiquitination in immune signaling.

Trends in immunology·2022
Same author

Correction: Regulation of ATG4B Stability by RNF5 Limits Basal Levels of Autophagy and Influences Susceptibility to Bacterial Infection.

PLoS genetics·2020
Same author

Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.

Frontiers in immunology·2019
Same author

Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding.

The Journal of biological chemistry·2018
Same author

Oxidized analogs of Di(1<i>H</i>-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity.

Oncotarget·2018
Same author

Tissue-Specific Immunoregulation: A Call for Better Understanding of the "Immunostat" in the Context of Cancer.

Cancer discovery·2018
Same journal

R&D productivity trends for biopharma companies in Asia and emerging markets.

Nature reviews. Drug discovery·2026
Same journal

Growth in clinical research capability in China and impact on the pharmaceutical sector.

Nature reviews. Drug discovery·2026
Same journal

Circular RNA guides exon skipping in DMD.

Nature reviews. Drug discovery·2026
Same journal

p38α inhibition restores axonal transport.

Nature reviews. Drug discovery·2026
Same journal

Inflammatory bowel disease-on-a-chip.

Nature reviews. Drug discovery·2026
Same journal

Designing GPCR-targeted miniproteins.

Nature reviews. Drug discovery·2026
See all related articles

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathology

Background:

  • Apoptosis, or programmed cell death, is a critical biological process.
  • Dysregulation of apoptosis is implicated in the pathogenesis of numerous diseases.
  • Impaired apoptosis can lead to either excessive cell accumulation or unwanted cell loss.

Purpose of the Study:

  • To review the role of apoptosis in disease.
  • To highlight the importance of understanding apoptotic mechanisms for drug discovery.

Main Methods:

  • Literature review of apoptosis research.
  • Analysis of genes and proteins involved in apoptosis regulation.
  • Examination of drug development strategies targeting apoptosis.

Related Experiment Videos

Main Results:

  • Defective apoptosis regulation contributes to various medical illnesses.
  • Identification of key apoptotic genes and proteins provides therapeutic targets.
  • Several apoptosis-targeting drugs are currently in clinical trials.

Conclusions:

  • Understanding apoptosis is crucial for addressing diseases linked to its dysfunction.
  • Targeting apoptotic pathways offers a promising avenue for novel therapeutic interventions.